Professor Matt Bellgard1
1Queensland University of Technology, Brisbane QLD
Universities generate considerable amounts of research data. Associated with this data are the five ‘Vs’ of data: Volume, Variety, Velocity, Veracity and Value that need to be continuously taken into consideration. Invariably, the combination of the V’s for any given research endeavour determine how best to deliver to the research output and outcome as well as to manage it at an institutional level addressing archiving, compliance, potential reuse for other research or for teaching purposes and so forth. As such, institutions are challenged with defining, shaping and refining their research data management strategy for the plethora of research data challenges to ensure there is consistency and adequate research data management practices in place. FAIR data principles are very important for the sharing of data for new collaborative open data opportunities, but typically, research data management practices need to be established in a robust way. In addition, new technology options have become available for institutions to make considered choices on whether to use ‘on prem’, private Cloud or public Cloud infrastructure; If a hybrid approach is adopted, then it needs to be determined what the impact might be on the established institutional research data management strategy. In this talk, I will provide an overview of the approaches being adopted at both an institutional and at a collaborative research project level. These approaches feather the incorporation of an analytic-centric focus rather than a data capture mindset.
Professor Bellgard is the inaugural eResearch Director at Queensland University of Technology and Chairs QUT’s Research Data Management Strategy Implementation Group. He has attracted over AUD$44m in research funding, is co-inventor of 5 patents and has co-authored over 140 articles. He has led the design and development of a diverse range of research data management approaches as well as digital health solutions, particularly for rare diseases, for government, industry and academia across multiple jurisdictions. He is also Chair of the APEC Life Science Innovation Forum Rare Disease Network.